Entrada Therapeutics, Inc. (TRDA)
6.64
-0.06
(-0.90%)
USD |
NASDAQ |
May 27, 16:00
6.64
0.00 (0.00%)
After-Hours: 16:33
Entrada Therapeutics Free Cash Flow : -131.64M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.710B |
| Tyra Biosciences, Inc. | -102.47M |
| Biogen, Inc. | 2.316B |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| XOMA Royalty Corp. | -14.09M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -41.70M |
| Cash from Investing (Quarterly) | 26.99M |
| Cash from Financing (Quarterly) | 0.10M |
| Free Cash Flow Per Share (Quarterly) | -0.9977 |
| Free Cash Flow to Equity (Quarterly) | -40.56M |
| Free Cash Flow to Firm (Quarterly) | -41.74M |
| Free Cash Flow Yield | -47.70% |